Bobby Sandage
InvestorGeneral Partner at Cultivation Capital · General Partner at Cultivation Capital Life Sciences · Board director at Immunophotonics, Inc.
St Louis, Missouri, United States
About
Bobby Sandage is Managing Director at the Paula and Rodger Riney Foundation and Lightchain Capital, LLC, a General Partner in Cultivation Capital Life Sciences Fund II, and serves on the boards of Predicta Biosciences, Immunophotonics, and Endevica Bio. His earlier roles include President and CEO of Euclises and of Coronado Biosciences, VP of Embedded Therapeutics at Covidien Pharmaceuticals, and executive vice president of research and development and chief scientific officer at Indevus Pharmaceuticals, along with senior drug development positions at DuPont Merck Pharmaceutical Company and DuPont Critical Care. He is an adjunct professor of pharmaceutical sciences at the Southern Illinois University at Edwardsville School of Pharmacy, holds a Ph.D. in clinical pharmacy from Pur
Contact· published on Bobby's own website
Board director at Immunophotonics, Inc.
Intro paths
→
In turn, Bobby can intro founders to Immunophotonics, Inc.'s investors below.
Immunophotonics, Inc.'s investors · 5
Co-founders at Immunophotonics, Inc.
DH
Dr. HodeCo-Founder & Senior Fellow
MA
Mr. AlleruzzoCo-Founder & Director
DC
Dr. ChenCo-Founder
DR
Dr. Robert NordquistCo-Founder
Experience
- Predicta BiosciencesMember Board of Directorscurrent2025 — present
- Paula and Rodger Riney FoundationManaging Directorcurrent2020 — presentSt Louis, Missouri, United States
- Endevica BioMember Board Of Directorscurrent2017 — presentColumbia, MO
- Immunophotonics IncBoard Membercurrent2014 — presentSt. Louis
- Cultivation Capital Life Sciences Fund II LLCGeneral Partnercurrent2016 — presentGreater St. Louis
- BioVentures, LLCBoard Membercurrent2019 — presentLittle Rock Metropolitan Area
- University of Arkansas for Medical Sciences College of Pharmacy Dean's Advisory CouncilMembercurrent2015 — presentLittle Rock, Arkansas
- Euclises Pharmaceuticals, Inc.President and CEO2015 — 2026Greater St. Louis
- NextRNA TherapeuticsBoard Member2022 — 2025Boston, Massachusetts, United States
- AI ProteinsBoard Member2022 — 2025Boston, Massachusetts, United States
- Microbial MachinesBoard Member2022 — 2025Boston, Massachusetts, United States
- GeneoscopyBoard Member2019 — 2025St Louis, Missouri, United States
- iSelect FundMember of Selection Committee2014 — 2023St. Louis
- Cultivation Capital Life Sciences Fund IMember of Investment Committee2014 — 2023Greater St. Louis
- Mateon TherapeuticsMember Board Of Directors2016 — 2019San Francisco Bay Area
- EDIS SolutionsMember Board of Directors2014 — 2015St. Louis
- VasculoxMember of the Board of Directors2014 — 2015St. Louis
- Gentium SpABoard Director2009 — 2014Como, Lombardy, Italy
- Coronado Biosciences, Inc.President and CEO2011 — 2013
- CovidienVP Embedded Therapeutics2010 — 2011
- Osteologix Inc.Board Director2005 — 2010
- Endo PharmaceuticalsEVP2009
- Indevus PharmaceuticalsEVP1991 — 2009
- Indevus PharmaceuticalsExecutive vice president of Research and Development1991 — 2009
- Dupont Merck PharmaceuticalsProject Manager, Head of Cardiovascular Drug Development1989 — 1991
- American Critical CareAssociate Medical Director1983 — 1986
Skills & more
CTMS11Drug Development99Regulatory Affairs99Clinical Development83Biotechnology82Oncology47Clinical Trials59FDA27Medical Devices38Technology Transfer27Lifesciences25Clinical Research23
+12 more
CancerMedicinePharmacologyBiopharmaceuticalsCardiologyRegulatory SubmissionsInformaticsPharmaceuticsR&DPharmaceutical IndustryProcess ImprovementNeuroscienceFrom Bobby's professional profile.
Investments
Board seats
Per SEC Form D filings.
Colleagues at Cultivation Capital
Andrew Dearing
General Partner at Cultivation Capital
Andy Cloyd
Principal at Cultivation Capital
Barry Sandweiss
General Partner at Cultivation Capital
Brian Matthews
Cofounder & General Partner at Cultivation Capital
Caleb Eidem
General Counsel at Cultivation Capital
Camila Petignat
Partner at The Yield Lab Latam
Catherine Matthes
Venture Advisor at Cultivation Capital
Cliff Holekamp
Cofounder & General Partner at Cultivation Capital
Frequently asked questions
- Who is Bobby Sandage?
- Bobby Sandage is Managing Director at the Paula and Rodger Riney Foundation and Lightchain Capital, LLC, a General Partner in Cultivation Capital Life Sciences Fund II, and serves on the boards of Predicta Biosciences, Immunophotonics, and Endevica Bio. His earlier roles include President and CEO of Euclises and of Coronado Biosciences, VP of Embedded Therapeutics at Covidien Pharmaceuticals, and executive vice president of research and development and chief scientific officer at Indevus Pharmaceuticals, along with senior drug development positions at DuPont Merck Pharmaceutical Company and DuPont Critical Care. He is an adjunct professor of pharmaceutical sciences at the Southern Illinois University at Edwardsville School of Pharmacy, holds a Ph.D. in clinical pharmacy from Pur
- Where does Bobby Sandage work?
- Bobby Sandage is General Partner at Cultivation Capital and Board director at Immunophotonics, Inc..
- What boards does Bobby Sandage sit on?
- Bobby Sandage holds tracked board seats at Geneoscopy, Inc, Immunophotonics, Inc..
- Where did Bobby Sandage go to school?
- Bobby Sandage studied at Purdue University (Ph.D., Clinical Pharmacy); University of Arkansas for Medical Sciences (BS, Pharmacy); Parkview High School.
Same school
Also attended Purdue University203
Mamoon HamidPartner at Kleiner PerkinsKenneth Morand, Ph.D.Life Sciences Partner at CincyTechJane CommerfordOperations at 8VCSven StrohbandInvestor at Khosla VenturesJeff PetersPartner at Ibex InvestorsKenneth MorandLife Sciences Partner at CincyTech
%20(1)%20(1).png)
+ 197 more
